search returned 100 results for adalimumab, showing results 11 to 20
PBS Therapeutic Update
PBAC Recommendations for adalimumab listing on the PBS... to the Pharmaceutical Benefts Scheme (PBS) listings for
adalimumab:
• new listing for enthesitis/spondylitis related... of the current PBS listings for adalimumab
for severe active JIA which include:
o reduced
https://rheumatology.org.au/LinkClick.aspx?fileticket=vcoX6pQ9qN0%3d
Professor Wilson
Re: Variation to indications for adalimumab in children with rheumatic...)
for variation to indications for adalimumab in children with rheumatic conditions.
As you are aware... and the extended Australian community.
The proposed variations will allow access to adalimumab in keeping
https://rheumatology.org.au/LinkClick.aspx?fileticket=K%2bIl5mcxmiQ%3d
Professor Wilson
Re: Variation to indications for adalimumab in children with rheumatic...)
for variation to indications for adalimumab in children with rheumatic conditions.
As you are aware... and the extended Australian community.
The proposed variations will allow access to adalimumab in keeping
https://rheumatology.org.au/LinkClick.aspx?fileticket=K-Il5mcxmiQ%3d&portalid=2
of adalimumab at the pharmacy level
With the introduction of several adalimumab biosimilars... of the biosimilar brand of
adalimumab at the community pharmacy level.
Specifically, we have received reports from patients where:
1. Pharmacists are refusing to stock the original brand of adalimumab
https://rheumatology.org.au/LinkClick.aspx?fileticket=FjUmmXFBR9g%3d
: chris.freeman@psa.org.au
Dear Chris
Re: Biosimilar substitution of adalimumab at the pharmacy level
With the introduction of several adalimumab biosimilars to the Pharmaceutical Benefits... of
adalimumab at the community pharmacy level.
Specifically, we have received reports from patients where
https://rheumatology.org.au/LinkClick.aspx?fileticket=L%2bdw5mND%2bOo%3d
of adalimumab at the pharmacy level
With the introduction of several adalimumab biosimilars... of the biosimilar brand of
adalimumab at the community pharmacy level.
Specifically, we have received reports from patients where:
1. Pharmacists are refusing to stock the original brand of adalimumab
https://rheumatology.org.au/LinkClick.aspx?fileticket=FjUmmXFBR9g%3d&portalid=2
: chris.freeman@psa.org.au
Dear Chris
Re: Biosimilar substitution of adalimumab at the pharmacy level
With the introduction of several adalimumab biosimilars to the Pharmaceutical Benefits... of
adalimumab at the community pharmacy level.
Specifically, we have received reports from patients where
https://rheumatology.org.au/LinkClick.aspx?fileticket=L-dw5mND-Oo%3d&portalid=2
With the introduction of several adalimumab biosimilars to the Pharmaceutical Benefits Scheme on
the 1..., the
subsequent changes in prescribing software, the introduction of four (4) adalimumab
https://rheumatology.org.au/LinkClick.aspx?fileticket=csAVeuirDZ4%3d
With the introduction of several adalimumab biosimilars to the Pharmaceutical Benefits Scheme on
the 1..., the
subsequent changes in prescribing software, the introduction of four (4) adalimumab
https://rheumatology.org.au/LinkClick.aspx?fileticket=csAVeuirDZ4%3d&portalid=2
Therapeutic Update
1 Dec PBS Changes for Ankylosing Spondylitis
As you may have heard, the PBS listing for medicines for ankylosing spondylitis
(adalimumab, etanercept and infiximab) have recently changed for biosimilars:
• Initial therapy will change from Authority Required (Written
https://rheumatology.org.au/LinkClick.aspx?fileticket=ldZvOYm4M4A%3d